FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Clinical Trial topics
Clinical Trial
Clinical Trials
Compliance
User Interface
Scheduling
Graphical User Interface
Stem Cells
Disaccharide
Amniotic Fluid
Antioxidant
Antioxidants
Bovine Serum
Electronic Device
Portable Electronic Device
Operational Data Store

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Clinical Trial patents



      
           
This page is updated frequently with new Clinical Trial-related patent applications. Subscribe to the Clinical Trial RSS feed to automatically get the update: related Clinical RSS feeds. RSS updates for this page: Clinical Trial RSS RSS


Research and development and market viability analysis framework for drugs, biologics and medical devices

Methods and systems for retrieval of experts based on user customizable search and ranking parameters

Date/App# patent app List of recent Clinical Trial-related patents
07/24/14
20140206561
 Method for providing information on antidepressant therapeutic effect using single nucleotide polymorphism patent thumbnailnew patent Method for providing information on antidepressant therapeutic effect using single nucleotide polymorphism
Disclosed is a method for providing information on the therapeutic effect of an ssri antidepressant by identifying tph2 gene polymorphism rs4760815, slc6a4 gene polymorphism 5-httlpr, slc6a4 gene polymorphism rs2066713, gad1 gene polymorphism rs3828275, and grik2 gene polymorphism rs543196. Through the disclosed method, it is possible to select an antidepressant based on genetic information, to prevent the worsening or relapse of depression, and to establish customized depression treatment models which are effective in the development of customized new drugs, and appropriate for korean people.
07/17/14
20140200954
 Research and development and market viability analysis framework for drugs, biologics and medical devices patent thumbnailResearch and development and market viability analysis framework for drugs, biologics and medical devices
A drug, biologic or medical device evaluation software tool for determining optimized research, development and commercialization pathways. The method comprises a) providing comparative clinical trial, value proposition and marketplace success predictors as metrics from a selected range of therapeutically relevant marketplace competitors anticipated at the time of the launch of the new product to a computer device b) assigning comparative benefit and risk scores to the product in research and development relative to these competitors c) incorporating specific feedback from physicians, health plans, healthcare service providers and payers to validate these scores d) offering scenario planning on multiple research, development and marketing options based on theoretical benefit and risk alternative scoring, and refined through various metric weighting and apportioning functions within the tool..
07/10/14
20140194467
 Plasma cell disorders patent thumbnailPlasma cell disorders
The invention relates to novel biological markers for plasma cell disorders, such as multiple myeloma, and in particular to the use of micrornas as diagnostic and prognostic markers in assays for detecting such disorders. The invention also relates to methods of determining the efficacy of treating a plasma cell disorder with a therapeutic agent, and kits for carrying 5 out the assays and methods.
06/26/14
20140181098
 Methods and systems for retrieval of experts based on user customizable search and ranking parameters patent thumbnailMethods and systems for retrieval of experts based on user customizable search and ranking parameters
Methods and systems for finding experts based upon user customizable search and ranking criteria, and providing the search results at a person or expert level are disclosed. The methods generally entail cataloging data within one or more document databases, and includes the steps of (a) inputting disparate data sources which may include publications, awarded grants, clinical trials, and/or patents; (b) processing the data within each document in the document database(s); (c) creating a document profile for each document using relevant keywords; (d) assigning weighting factors to the relevant keywords based upon selected attributes; (e) assigning an identifier to each document and document author; (f) removing duplicate document data using a disambiguation algorithm; (g) extracting author level attributes from the retrieved documents; and (h) creating or updating each document profile.
06/12/14
20140164265
 Clinical trial adverse event reporting system patent thumbnailClinical trial adverse event reporting system
A system is provided that sends data to a safety compliance management system in response to an adverse event. The system receives a first event in response to a first interaction by a user, where the first event indicates that the adverse event is to be reported to the safety compliance management system.
06/12/14
20140164015
 Clinical trial adverse event data change reporting system patent thumbnailClinical trial adverse event data change reporting system
A system is provided that sends data changes to a safety compliance management system. The system defines at least one data field as a significant data field.
06/12/14
20140162901
 Needle array assembly and method for delivering therapeutic agents patent thumbnailNeedle array assembly and method for delivering therapeutic agents
A fluid delivery device includes an array of needles, each in fluid communication with a respective reservoir. Respective actuators are coupled so as to be operable to drive fluid from the reservoirs via needle ports.
06/12/14
20140162360
 Needle array assembly and method for delivering therapeutic agents patent thumbnailNeedle array assembly and method for delivering therapeutic agents
A fluid delivery device includes an array of needles, each in fluid communication with a respective reservoir. Respective actuators are coupled so as to be operable to drive fluid from the reservoirs via needle ports.
06/12/14
20140160436
 System and method for evaluating intraocular lens performance patent thumbnailSystem and method for evaluating intraocular lens performance
Systems and methods for providing improved techniques for evaluating performance of intraocular lenses. Such techniques can be used to evaluate lens designs and can help reduce the need for multiple clinical trials that may otherwise be needed to evaluate multiple design iterations.
06/12/14
20140158126
 Drug delivery device for the treatment of patients with respiratory diseases patent thumbnailDrug delivery device for the treatment of patients with respiratory diseases
Drug delivery devices that include a microphone and processing circuitry that can detect operating events, such as peak inspiratory flow (pif) and breath actuated mechanism (bam) in dry powder inhalers can be used to improve clinical trials by providing information about the way in which the inhalers under test are being used.. .
06/05/14
20140155731
Method for identifying neuroprotective compounds and/or neuroregeneration stimulators by fractional anisotropy measurements by diffusion-based mri scanning
The present invention relates to a method for monitoring the effectiveness of a treatment on neuroprotection and to a method for identifying candidate molecules that are neuroprotectors and/or neuronal growth stimulators. The present invention can be used, in particular, in the field of pharmaceutics, in the field of scientific research and in the field of clinical trials and validation of therapeutic substances..
06/05/14
20140155424
Naltrexone long acting formulations and methods of use
The inventions described herein arose from unexpected discoveries made during clinical trials with a long acting formulation of naltrexone. As such, the invention includes a method for treating an individual in need of naltrexone comprising the step of parenterally administering a long acting formulation comprising naltrexone and to the use of naltrexone in the manufacture of medicaments for use in such methods..
05/22/14
20140142968
Online, interactive evaluation of research performance
Medical and other research organizations, sites within those organizations, and physicians practicing at those sites register in an online database. The company providing the database posts a description of a clinical trial opportunity or other research opportunity.
05/15/14
20140136228
Systems and methods for composing profiles of clinical trial capacity for geographic locations
The invention generally relates to systems and methods for composing location profiles for use in planning clinical trials. Location profiles may depict the aggregate clinical research capacity of geographic locations based on research centers within those locations among other factors.
05/08/14
20140129253
Apparatus and method for managing medication adherence
A system and method of a clinical trial is provided. The system comprises a summary page providing an overview of each clinical trial participant in a graphical format, each clinical trial participant being represented by a unique clinical trial participant identifier and one or more clinical trial participant identifier modifiers applicable to modify one or more of the clinical trial participant identifiers, each modifier indicative of a different status of the particular participant identifier to which it is applied.
05/01/14
20140122113
Providing indications of clinical-trial criteria modifications
Systems and method for providing indications of trial-related attributes are provided. In embodiments, the method includes providing an indication to view a suggested clinical-trial criteria modification(s) that, if implemented, is expected to increase a number of patients eligible for a clinical trial.
04/17/14
20140108032
Clinical monitoring device with time shifting capability
The present invention is designed to develop research protocols for clinical trials. The invention can track and enhance subject compliance with a research protocol.
04/17/14
20140102934
Packaging for medicine for clinical trials or commercial use
A package for receiving a vial may include an inner portion folded into a first shape configured to receive the vial; an outer portion folded into a second shape configured to removably receive the first shape of the inner portion; and an identifying mark or label disposed on the inner portion and viewable when the inner portion is disposed within the outer portion. The inner portion may include top, bottom, and first and second side portions that define a first aperture configured to receive the vial, and a top flap securable to the top or first or second side portions so as to retain the vial within the first aperture.
03/27/14
20140086887
Adult stem cell line introduced with hepatocyte growth factor gene and neurogenic transcription factor gene with basic helix-loop-helix motif and uses thereof
The present invention relates to an adult stem cell line introduced with an hgf gene and a neurogenic transcription factor gene of a bhlh family, a preparation method of the adult stem cell line, a composition for the prevention or treatment of neurological diseases comprising the adult stem cell line, and a method for treating neurological diseases comprising the step of administering the composition to a subject having neurological diseases or suspected of having neurological diseases. The adult stem cells according to the present invention, which are introduced with an hgf gene and a neurogenic transcription factor gene of a bhlh family, can be used to overcome chronic impairment caused by cell death following stroke.
03/13/14
20140072602
Micelle encapsulation of a combination of therapeutic agents
The invention provides active agents, such as paclitaxel, rapamycin, or 17-dmag, encapsulated by safe poly(ethylene glycol)-block-poly(lactic acid) (“peg-b-pla”) micelles. The compositions provide effective solubilization of drug combinations, such as paclitaxel, rapamycin, and 17-dmag, as well as others described herein.
02/27/14
20140058752
Computer network for quality testing clinical trial data
A computer network system and a method for quality testing input clinical trial data are disclosed. The trial data is recorded by way of a form provided on a patient device or a physician device and is passed on in an encrypted, anonymized form to a central server.
02/27/14
20140058683
Methods for assessing drug efficacy and response of a patient to therapy
Methods of identifying, monitoring and matching patients with appropriate treatments using a systemic mediator-associated physiologic test profile are provided. The methods of the present invention increase the likelihood of demonstrating clinical efficacy in clinical trial datasets..
02/20/14
20140051773
Methods for predicting risk of developing hypertension
Methods using biomarkers, e.g., serum levels of st2, to predict risk of developing hypertension, as well as methods for treating subjects to reduce the risk of developing hypertension and methods for selecting and/or stratifying subjects for clinical trials of treatments to reduce the risk of hypertension.. .
02/13/14
20140047570
Animal model of human cancer and methods of use
The subject invention pertains to a non-human animal model of human cancer, methods of producing a non-human animal model of human cancer, methods of using a non-human animal model to propagate human cancer cells, methods of using a non-human animal model to study cancer, methods of using a non-human animal model to screen potential treatments for a subject's cancer, methods of using a non-human animal model for treating cancer in a subject (providing personalized therapy), methods of using a non-human animal model for identifying a biomarker of cancer treatment; and methods of using a non-human animal model for selecting cancer patients for a clinical trial.. .
02/13/14
20140046147
Pharmaceutical dosages delivery system
Pharmaceutical delivery systems for delivering dosages according to the present invention include a carrier component and a cap configured to seal an internal volume of the carrier component, wherein the cap includes a device that produces a unique current signature. Dosages prepared to be delivered according to embodiments of the invention find use in a variety of different applications, including clinical trials..
02/06/14
20140039921
Design assistance for clinical trial protocols
Roughly described, a user instantiates protocol elements in a structured clinical trial protocol database and then draws from them in the development of one or more protocol related documents. The system helps the user select tasks to be performed during the study by reference to a historical database of tasks previously associated with similar protocols.
01/30/14
20140032229
Method of payment assessment to clinical study volunteers
Systems, methods, and other embodiments associated with generating payments to volunteers in clinical trials are described. In one embodiment, a method includes receiving volunteer data that specifies a clinical event that has been completed by a given volunteer.
01/30/14
20140031291
Pp2a regulatory subunit modification in disease
Disclosed herein are methods for the diagnosis, detection, and treatment of cardiovascular disease and symptoms thereof in a subject. Disclosed herein are methods of diagnosing ischemic heart disease, non-ischemic heart disease, myocardial infarction, tachy-pacing induced non-ischemic heart disease, heart failure, and catecholaminergic-induced arrhythmia and symptoms thereof in a subject.
01/02/14
20140006042
Methods for conducting studies
Provided herein are methods, devices, systems, and computer readable medium for improving studies such as clinical trials and for improving clinical practice. The methods, devices, systems, and computer readable medium provided herein can be used to identify outlier data in a study, select data collection sites likely to produce high quality data, detect fraud, identify placebo responders, and/or identify likely responders to a therapy.
12/26/13
20130346101
Clinical trials management system and method
Protocol meta-models are made available to a protocol designer. Each protocol meta-model includes a list of preliminary patient eligibility attributes appropriate for a particular disease category.
12/26/13
20130346094
Systems and methods for predictive analytics for site initiation and patient enrollment
Methods and systems for predictive analytics for site initiation and patient enrollment are disclosed. One method may include: receiving a user's selection of one or more parameters associated with a clinical trial; accessing a database of data associated with a plurality of previous clinical trials; comparing the one or more parameters to the previous clinical trials; determining one or more factors associated with the clinical trial based on the comparison; and displaying the parameters and the factors on a display..
12/19/13
20130339058
Medical information event manager
An event management system and method detects the occurrence of events as a function, at least in part, of information and data gathered from monitoring one or more patients with a medical information system. Event detection processes can be defined and then triggered to cover any of a variety of circumstances.
12/19/13
20130339030
Interactive spoken dialogue interface for collection of structured data
A multimodal dialog interface for data capture at point of origin is disclosed. The interface is designed to allow loading of forms needed for task record keeping, and is therefore customizable to wide range of record keeping requirements such as medical record keeping or recording clinical trial.
12/12/13
20130332191
Identifying patient eligibility for clinical trials
Systems and method for facilitating clinical-trial referrals are provided. In embodiments, the method includes searching clinical-trial data associated with a plurality of clinical trials to identify one or more clinical trials for which a patient is eligible to participate based on patient data associated with the patient.
12/12/13
20130332190
Providing indications of clinical-trial criteria modifications
Systems and method for providing indications of trial-related attributes are provided. In embodiments, the method includes providing an indication to view a suggested clinical-trial criteria modification(s) that, if implemented, is expected to increase a number of patients eligible for a clinical trial.
12/05/13
20130323696
System and method for task-based training assignment for training on clinical trials
The invention provides a method and system for efficiently apportioning, delivering and monitoring training to clinical trial participants. The invention ensures that each person participating in a given clinical trial receives only the training that they actually need in order to perform their assigned tasks on the trial.
11/28/13
20130316965
Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events
The invention relates to idrabiotaparinux for use in the treatment of pulmonary embolism in patients with or without deep venous thrombosis and for the secondary prevention of venous thromboembolic events in said patients, wherein the efficacy and safety of said uses are clinically proven by a phase iii clinical trial.. .
11/14/13
20130304504
System and method for clinical trial design
A method of collecting input from individuals comprising searching a database containing a plurality of individual's electronic health records (ehrs), assigning a unique patient key to each individual's ehr and removing the individual's identifying characteristics from the ehr with a computer having a memory and a processor operating a hipaa privacy filter to provide de-identified ehrs, maintaining a confidential record of each individual's identifying characteristics associated with the unique patient key. De-identified ehrs are analyzed to define members of a target group.
11/14/13
20130304484
Clinical trials subject identification system
Matching a subject with a clinical trial includes steps of: collecting patient data associated with the subject; collecting clinical trial data from multiple sources; matching the subject to a clinical trial scheduled in a location accessible to the subject; notifying a health care provider associated with the subject about the clinical trial; and receiving a response.. .
11/07/13
20130295640
Methods and reagents for preparing multifunctional probes
Multifunctional probes are synthesized in a single step using peptide scaffold-based multifunctional single-attachment-point reagents. To obtain multifunctional probes of the invention, a substrate (e.g., a nanoparticle, polymer, antibody, protein, low molecular weight compound, drug, etc.) is reacted with a multifunctional single-attachment-point (msap) reagent.
10/31/13
20130290014
Method of equipoise enrollment of subjects in clinical trials
In a method of enrollment selection of subjects for a clinical trial, a plurality of physician investigators is polled regarding each subject of a plurality of subjects. Responses of the plurality of physician investigators are aggregated for each subject.
10/31/13
20130290008
Staff assignment for clinical trials
Systems, methods, and other embodiments associated with a graphical user interface for scheduling clinical staff are described. In one embodiment, a method includes generating a schedule for a plurality of events.
10/24/13
20130280755
Therapeutic methods for solid delivery
A fluid-delivery device includes an array of needles. The needle can deposit a hollow and/or porous tube into a tissue of a subject, and the porous tube can contain one or more fluid agents.
10/10/13
20130268287
System for clinical trial subject compliance
The present invention is designed to develop research protocols for clinical trials. The invention also can track and enhance subject compliance with a research protocol.


Popular terms: [SEARCH]

Clinical Trial topics: Clinical Trial, Clinical Trials, Compliance, User Interface, Scheduling, Graphical User Interface, Stem Cells, Disaccharide, Amniotic Fluid, Antioxidant, Antioxidants, Bovine Serum, Electronic Device, Portable Electronic Device, Operational Data Store

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Clinical Trial for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Clinical Trial with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.9749

3574

4 - 0 - 71